» Articles » PMID: 31282945

The Contribution of Ototoxic Medications to Hearing Loss Among Older Adults

Overview
Specialty Geriatrics
Date 2019 Jul 9
PMID 31282945
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ototoxicity may interact with the effects of aging, leading to a more severe hearing loss than that associated with age alone. The purpose of this study was to explore the associations between ototoxic medication use and the incidence and progression of hearing loss in older adults with a population-based longitudinal study.

Methods: Epidemiology of Hearing Loss Study participants (n = 3,753) were examined. Medication use was assessed using a standardized questionnaire by the examiners at each examination every 5 year. The ototoxic medications include loop diuretics, nonsteroidal anti-inflammatory drugs, antibiotics, chemotherapeutic agents, quinine, and acetaminophen in this study. Generalized estimating equations model was used as a proportional hazard discrete time analysis.

Results: Number of ototoxic medications was associated with the risk of developing hearing loss during the 10-year follow-up period (hazard ratio [HR] = 1.15, 95% confidence interval [CI] = 1.06, 1.25) after adjusting for age, sex, smoking, and body mass index. Loop diuretics (HR = 1.40, 95% CI = 1.05, 1.87) were associated with the 10-year incidence of hearing loss. Nonsteroidal anti-inflammatory drugs (HR = 1.45, 95% CI = 1.22, 1.72) and loop diuretics (HR = 1.33 95% CI = 1.08, 1.63) were associated with risk of progressive hearing loss over 10 years.

Conclusion: These ototoxic medications are commonly used in older adults and should be considered as potentially modifiable contributors to the incidence and severity of age-related hearing loss.

Citing Articles

Working behaviors and the risk of sensorineural hearing loss: A large cohort study.

Pang W, Song Y, Xie J, Yan X, Luo Y, Qiu K Scand J Work Environ Health. 2025; 51(2):77-88.

PMID: 39946747 PMC: 11892729. DOI: 10.5271/sjweh.4209.


Association between hypertension and hearing loss: a systemic review and meta-analysis.

Jin X, Xu X, Wang J, Liu X, Deng X, Xie H Front Neurol. 2025; 15():1470997.

PMID: 39839866 PMC: 11748549. DOI: 10.3389/fneur.2024.1470997.


Age-related hearing loss in older adults: etiology and rehabilitation strategies.

Zheng Q, Xu Z, Li N, Wang Y, Zhang T, Jing J Front Neurosci. 2024; 18:1428564.

PMID: 39411148 PMC: 11473498. DOI: 10.3389/fnins.2024.1428564.


Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes.

Tabibzadeh N, Wang D, Karaboyas A, Schaeffner E, Jacobson S, Vega A Clin Kidney J. 2024; 17(7):sfae141.

PMID: 38989279 PMC: 11233991. DOI: 10.1093/ckj/sfae141.


Traditional Chinese medicine for the prevention and treatment of presbycusis.

Yan L, Huo Y, Shi J, Dong Y, Tan H Heliyon. 2023; 9(12):e22422.

PMID: 38076135 PMC: 10703638. DOI: 10.1016/j.heliyon.2023.e22422.


References
1.
Rybak L, Ramkumar V . Ototoxicity. Kidney Int. 2007; 72(8):931-5. DOI: 10.1038/sj.ki.5002434. View

2.
Moscicki E, Elkins E, Baum H, MCNAMARA P . Hearing loss in the elderly: an epidemiologic study of the Framingham Heart Study Cohort. Ear Hear. 1985; 6(4):184-90. View

3.
Jung T, Rhee C, Lee C, Park Y, Choi D . Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am. 1993; 26(5):791-810. View

4.
Dubno J, Eckert M, Lee F, Matthews L, Schmiedt R . Classifying human audiometric phenotypes of age-related hearing loss from animal models. J Assoc Res Otolaryngol. 2013; 14(5):687-701. PMC: 3767874. DOI: 10.1007/s10162-013-0396-x. View

5.
Linton K, Klein B, Klein R . The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol. 1991; 134(12):1438-46. DOI: 10.1093/oxfordjournals.aje.a116049. View